Latest filing published 07 Jan 2015 for PROVECTUS BIOPHARMACEUTICALS, INC., €41k.
Insider track record
No signal scores available.
Timothy Scott PhD: trading record in brief
Timothy Scott PhD appears in our data through filings on Provectus Biopharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 8 filings cover trades dated from 6 October 2011 to 7 January 2015.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 7 January 2015 came the latest disclosure, an option exercise for €41k in Provectus Biopharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Timothy Scott PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 76,764 shares@ US$0.64Common StockSEC:0001140361-15-000967:0
- 126,361 shares@ US$0.64Common StockSEC:0001140361-14-046713:0
- 96,875 shares@ US$0.64Common StockSEC:0001209191-14-065651:0
- 25,000 shares@ US$0.95Common StockSEC:0001209191-14-035377:0
- 300,000 shares@ US$1.10Common StockSEC:0001140361-14-010097:0
- 75,000 shares@ US$0.32Common StockSEC:0001140361-11-048635:0
- 25,000 shares@ US$0.60Common StockSEC:0001140361-11-048635:1
7 of 7 declarations